文献速递腹部技术与安全USMR

超声衰减成像与受控衰减参数及磁共振波谱检测肝脂肪变性的对比研究

A Comparative Study of Ultrasound Attenuation Imaging, Controlled Attenuation Parameters, and Magnetic Resonance Spectroscopy for the Detection of Hepatic Steatosis.
PubMed 文献 · J Ultrasound Med · 2022-12-30

该前瞻性研究纳入159例NAFLD患者,在1H-MRS前一周内行CAP和ATI检查,评估ATI的观察者内一致性及ATI与CAP对肝脂肪变性的诊断效能。结果显示ATI观察者内ICC为0.931,最少需4次测量;ATI诊断≥10%和>33%肝脂肪变性的AUC分别为0.939和0.751,优于CAP。

要点

  • ATI观察者内一致性优秀(ICC=0.931),最少需4次测量即可替代10次测量。
  • ATI诊断≥10%肝脂肪变性的AUC为0.939,敏感度85.92%,特异度94.12%。
  • ATI诊断>33%肝脂肪变性的AUC为0.751,敏感度87.50%,特异度54.37%。

局限性

  • 单中心前瞻性研究,样本量159例。
  • 未报告组间一致性及重复性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the methodology and clinical application of ultrasound attenuation imaging (ATI) and comparative analyze the diagnostic performance of ATI and controlled attenuation parameters (CAP) for detecting and grading hepatic steatosis.

METHODS: A total of 159 patients with NAFLD were prospectively enrolled. CAP and ATI examinations were performed within a week before proton magnetic resonance spectroscopy (1 H-MRS). Ten liver attenuation coefficient (AC) measurements by ATI were obtained in each patient. The interclass correlation coefficients (ICCs) of the intraobserver consistencies and the ICCs between the median of the first two through the first nine measurements and all 10 measurements were calculated. The correlations between 1 H-MRS, CAP, biological data, and ATI were evaluated. The significant factors associated with ATI and the diagnostic performance of ATI and CAP for detecting hepatic steatosis was evaluated.

RESULTS: The median value of AC for detecting hepatic steatosis was 0.831 dB/cm/MHz. For the intraobserver consistency of ATI, the ICC was 0.931. Compared with 10 measurements, a minimum of four ATI measurements was required. The correlation of AC with hepatic fat fraction (HFF) was significantly higher than that of CAP (0.603 vs 0.326, P = .0015). The HFF and triglyceride (TG) were the significant factors for the ATI. The area under the receiver operating characteristics (ROC) curves of ATI and CAP were 0.939 and 0.788 for detecting ≥10% hepatic steatosis; 0.751 and 0.572 for detecting >33% hepatic steatosis. The cutoff values of ATI and CAP were 0.697 dB/cm/MHz and 310 dB/m for detecting ≥10% hepatic steatosis; 0.793 dB/cm/MHz and 328 dB/m for detecting >33% hepatic steatosis. The sensitivity of ATI and CAP were 85.92% and 52.11% for detecting ≥10% hepatic steatosis; 87.50% and 82.14% for detecting >33% hepatic steatosis. The specificity of ATI and CAP were 94.12% and 100% for detecting ≥10% hepatic steatosis; 54.37% and 43.69% for detecting >33% hepatic steatosis.

CONCLUSIONS: ATI technology showed excellent intraobserver consistency and the optimal minimum number of ATI measurements was 4. ATI is a promising noninvasive, quantitative and convenient tool for assessing hepatic steatosis.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Bao, Lv, Wang, et al. A Comparative Study of Ultrasound Attenuation Imaging, Controlled Attenuation Parameters, and Magnetic Resonance Spectroscopy for the Detection of Hepatic Steatosis. J Ultrasound Med. 2022. PMID: 36583414. doi:10.1002/jum.16158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。